Collaborations

• Combinatorial Personalized Approaches for Subtyping and Targeting Functional Heterogeneity in Pancreatic Ductal AdenoCarcinoma (COMBAT-PDAC)
  
  The grant is provided by the European Regional Development Fund (ERDF) and tax revenue from the budget approved by the Saxon State Parliament.

• BMBF Clusters 4 Future “SaxoCell”: "Universelle KI-geführte Designer-CAR-T-Zell-Therapie gegen Tumor-, Entzündungs- und Autoimmunerkrankungen (UniK-T)" http://www.saxocell.de/

• Third-funding project: „KI‐basierte Entwicklung tumorspezifischer CAR‐T‐Zell‐Immuntherapie beim malignen Melanom (KI-CARs)", funded by Sächsische Aufbaubank
  https://www.hzdr.de/db/Cms?pOid=72231&pNid=3438

• HORIZON-EIC-2022-PATHFINDERCHALLENGES-01: "B-cell related gene and protein markers with prognostic and therapeutic value for CVD (B-specific)", https://www.bspecific.eu

• Helmholtz Biomedical Engineering: https://www.helmholtz-bioengineering.de/

• HORIZON- Marie Skłodowska-Curie Actions (MSCA)-Doctoral Networks: “An integrated approach to restore tolerance in autoimmune disease (TOLERATE)”,
  https://www.tolerate-horizon.eu/

  

• HORIZON- Marie Sklodowska-Curie Actions (MSCA)-Doctoral Networks: “Protease-guided tumor targeting tools to revolutionize cancer diagnosis and treatment (OncoProTools)”, https://www.uantwerpen.be/en/projects/protease-guided-tumor-targeting-tools/

• Helmholtz Association: Initiative “Immunology & Inflammation”
  https://www.helmholtz-hzi.de/en/news-events/news/view/article/complete/joining-forces-for-immune-research/

• Helmholtz International Lab: “Monash-Helmholtz Laboratory for Radio-Immuno-Theranostics (MHELTHERA)”,
  https://www.hzdr.de/db/Cms?pNid=1202
  

• Else-Kröner-Fresenius-Stiftung (EKFS)-Ausschreibung “Projekte zur Verhinderung von Infektionen durch Tröpfchen oder Aerosole“: “Neuartige Inhalationstherapeutika zum Schutz vor viralen Infekten bedingt durch Tröpfcheninfektionen (Viroprotect)“

• Free State of Saxony, SAB Project: “Immuntheranostik zur Therapie, Bildgebung und Schnelldiagnostik von Viruserkrankungen: COVID-19“

• BMBF Clusters 4 Future “SaxoCell”: “Development of theranostic target molecules for diagnosis and therapy (TheraSTAR)“,
  http://www.saxocell.de/
  

• Mildred-Scheel-Nachwuchszentrum (MSNZ): “Engineered T-cells for personalized cancer therapy”,
  https://tu-dresden.de/med/mf/msnz/kollegiaten/claudia-arndt-frederick-fasslrinner